Formulating for the Future of Transplant Patient Therapy
Veloxis is a specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is an international company with headquarters in Hørsholm, Denmark, and a fully owned subsidiary in Edison, New Jersey, USA.
UK: +44(0)20 7136 2055
US: +1718 354 1359
Denmark: +4538 48 75 13
Start time: 3:00 pm CET
Please dial in for your pre-conference 30 prior to the scheduled start time.
Confirmation Code: 1720884